rs200197424
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_005149.3(TBX19):c.535C>T(p.Arg179Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000471 in 1,613,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000049 ( 0 hom. )
Consequence
TBX19
NM_005149.3 stop_gained
NM_005149.3 stop_gained
Scores
3
3
1
Clinical Significance
Conservation
PhyloP100: 3.91
Genes affected
TBX19 (HGNC:11596): (T-box transcription factor 19) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. Mutations in this gene were found in patients with isolated deficiency of pituitary POMC-derived ACTH, suggesting an essential role for this gene in differentiation of the pituitary POMC lineage. ACTH deficiency is characterized by adrenal insufficiency symptoms such as weight loss, lack of appetite (anorexia), weakness, nausea, vomiting, and low blood pressure. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
?
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
?
Very rare variant in population databases, with high coverage;
PP5
?
Variant 1-168293210-C-T is Pathogenic according to our data. Variant chr1-168293210-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 293458.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=2}. Variant chr1-168293210-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBX19 | NM_005149.3 | c.535C>T | p.Arg179Ter | stop_gained | 3/8 | ENST00000367821.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBX19 | ENST00000367821.8 | c.535C>T | p.Arg179Ter | stop_gained | 3/8 | 1 | NM_005149.3 | P1 | |
TBX19 | ENST00000431969.5 | c.334C>T | p.Arg112Ter | stop_gained | 2/6 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.0000330 AC: 5AN: 151698Hom.: 0 Cov.: 31
GnomAD3 genomes
?
AF:
AC:
5
AN:
151698
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251378Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135864
GnomAD3 exomes
AF:
AC:
14
AN:
251378
Hom.:
AF XY:
AC XY:
6
AN XY:
135864
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1461718Hom.: 0 Cov.: 58 AF XY: 0.0000509 AC XY: 37AN XY: 727160
GnomAD4 exome
AF:
AC:
71
AN:
1461718
Hom.:
Cov.:
58
AF XY:
AC XY:
37
AN XY:
727160
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000329 AC: 5AN: 151816Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74176
GnomAD4 genome
?
AF:
AC:
5
AN:
151816
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74176
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
?
AF:
AC:
5
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2023 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 15613420, 31589614, 33423260, 33098107, 12651888) - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | May 15, 2022 | This sequence change creates a premature translational stop signal (p.Arg179*) in the TBX19 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TBX19 are known to be pathogenic (PMID: 22170728). This variant is present in population databases (rs200197424, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with isolated adrenocorticotropic hormone deficiency (PMID: 12651888, 33423260). ClinVar contains an entry for this variant (Variation ID: 293458). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Congenital isolated adrenocorticotropic hormone deficiency Pathogenic:1Uncertain:1
Pathogenic, no assertion criteria provided | clinical testing | Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital | May 28, 2014 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Nov 13, 2017 | The TBX19 c.535C>T (p.Arg179Ter) is a stop-gained variant that is predicted to result in premature termination of the protein. The p.Arg179Ter variant has been reported in a single study in which it was identified in a homozygous state in one individual with neonatal onset ACTH deficiency and in a heterozygous state in the unaffected consanguineous parents (Pulichino et al. 2003). Control data are unavailable for this variant, which is reported at a frequency of 0.00004 in the European (non-Finnish) population of the Exome Aggregation Consortium. Based on the evidence and potential impact of stop-gained variants, the p.Arg179Ter variant is classified as a variant of unknown significance, but suspicious for pathogenicity, for ACTH deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
Cadd
Pathogenic
Dann
Uncertain
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A
Vest4
ClinPred
D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at